Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis
Dara A. Lehman(Johns Hopkins University), Craig R. Cohen(University of California, San Francisco), James Kiarie(World Health Organization), Katherine K. Thomas(University of Namur), Jonathan Wangisi(The AIDS Support Organization), Carey Farquhar(University of Washington), Elizabeth A. Bukusi(University of California, San Francisco), Lisa M. Frenkel(Infectious Disease Research Institute), E. Katabira(Faculty of Public Health), Nelly Mugo(University of Washington), A. Ronald(Faculty of Public Health), D E Peterson, Grace John‐Stewart(Washington State Department of Health), Craig W. Hendrix(Unknown), Robert W. Coombs(University of Namur), Patrick Ndase, Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Edwin Were(University of Namur), Jordan W. Tappero, Connor O. McCoy(Faculty of Public Health), Julie Overbaugh(Gold Coast Hospital), Mark A. Marzinke(Family Health International 360), M. Juliana McElrath(Fred Hutch Cancer Center), F. A. Matsen(Howard Hughes Medical Institute), Julie F. Weis, G. Mbara(Center for Global Health), E. Tumwesigye, Jairam R. Lingappa(University of Namur), K H Fife(University of Namur)
Cited by 101
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891